Background illustration for clinical trials search

Paid Clinical Trials Allentown

Discover 2,147 paid clinical trials in Allentown, Pennsylvania. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

CD5-deleted Chimeric Antigen Receptor Cells (Senza5 CART5) for T Cell Non-Hodgkin Lymphoma (NHL)

for
T Cell Non-Hodgkin Lymphoma
Location: Philadelphia PA, New York NY
Sponsor: Vittoria Biotherapeutics

Sex: All

Age: 18+

Code: NCT06420089

Phase1, Recruiting

Clinical Study to Evaluate the Safety and Effectiveness of Arcevo LSA

for
Aortic Arch Aneurysm, Aortic Arch Dissection,
Location: Philadelphia PA, New York NY, The Bronx NY,
Sponsor: Artivion Inc.

Sex: All

Age: 18 - 70+

Code: NCT07089576

Recruiting

Role of the Immune Environment in Response to Therapy in Breast Cancer

for
Breast Cancer, ER Positive Breast Cancer,
Location: Philadelphia PA
Sponsor: Abramson Cancer Center at Penn Medicine

Sex: Female

Age: 18+

Code: NCT05396612

Recruiting

ETHAN - ET for Male BC

for
Male Breast Cancer, Hormone Receptor-positive Breast Cancer,
Location: Philadelphia PA, Washington D.C. DC, Pittsburgh PA,
Sponsor: Jose Pablo Leone

Sex: Male

Age: 18+

Code: NCT05501704

Phase2, Recruiting

Carboplatin, Taxane And Ramucirumab for Patients With NSCLC After Pemetrexed or Pembrolizumab Maintenance

for
Non-small Cell Lung Cancer
Location: Philadelphia PA
Sponsor: Abramson Cancer Center at Penn Medicine

Sex: All

Age: 18+

Code: NCT04332367

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

for
Advanced Cancer, Metastatic Cancer, Ovarian Cancer,
Location: Philadelphia PA, Lake Success NY, Columbia MD,
Sponsor: Artios Pharma Ltd

Sex: All

Age: 18+

Code: NCT04657068

Phase1, Phase2, Recruiting

A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)

for
Locally Advanced Solid Tumor, Metastatic Solid Tumor
Location: Philadelphia PA, New York NY, Baltimore MD,
Sponsor: Nuvalent Inc.

Sex: All

Age: 12+

Code: NCT05384626

Phase1, Phase2, Recruiting

Tagraxofusp and Azacitidine With Venetoclax in Newly Diagnosed Secondary AML After Hypomethylating Agents

for
Acute Myeloid Leukemia
Location: Philadelphia PA, Providence RI, Buffalo NY,
Sponsor: Joshua Zeidner

Sex: All

Age: 18+

Code: NCT05442216

Phase2, Recruiting

A Study of PYX-201 in Advanced Solid Tumors

for
Solid Tumor, Advanced Solid Tumor
Location: Philadelphia PA, New York NY, Fairfax VA, Providence RI,
Sponsor: Pyxis Oncology, Inc

Sex: All

Age: 18+

Code: NCT05720117

Phase1, Recruiting

Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib

for
Myelofibrosis, Post-PV MF, Post-ET Myelofibrosis,
Location: Philadelphia PA, Newark DE, Hackensack NJ, New York NY,
Sponsor: Kartos Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06479135

Phase3, Recruiting

[18F]FES PET/.CT in Uterine Cancer

for
Uterine Cancer
Location: Philadelphia PA
Sponsor: Abramson Cancer Center at Penn Medicine

Sex: Female

Age: 18+

Code: NCT05916196

Phase2, Recruiting

Tebentafusp-tebn With LDT in Metastatic UM

for
Metastatic Uveal Melanoma
Location: Philadelphia PA
Sponsor: Thomas Jefferson University

Sex: All

Age: 18+

Code: NCT06626516

Phase1, Phase2, Recruiting

A Study Evaluating the Safety and Efficacy of Glofitamab + Gemcitabine + Oxaliplatin in U.S. Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

for
Lymphoma
Location: Philadelphia PA, Stony Brook NY, Chicago IL, Orlando FL,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT06624085

Phase1, Recruiting

A Prospective, Randomized, Single-blind, Controlled, Multi-center Study to Assess the Safety and Performance of MagnetOsTM Compared to Autogenous Bone Graft in Patients Undergoing Hindfoot or Ankle Fusions.

for
Ankle Arthrodesis or Arthroplasty, Hindfoot Fusion,
Location: Philadelphia PA, Falls Church VA, Charlotte NC,
Sponsor: Kuros Biosurgery AG

Sex: All

Age: 18 - 70+

Code: NCT07225751

Recruiting

Study of Senaparib in Combination With Temozolomide in ARID1A Mutation Associated Ovarian Cancer

for
Ovary Cancer, Fallopian Tube Cancer,
Location: Philadelphia PA, Baltimore MD
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Sex: Female

Age: 18+

Code: NCT06617923

Phase2, Recruiting

Tocilizumab and Atezolizumab in Adults With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Refractory to 1st Line Immune Checkpoint Inhibitor-Based Therapy

for
Lung Cancer, Nonsmall Cell
Location: Philadelphia PA
Sponsor: Abramson Cancer Center at Penn Medicine

Sex: All

Age: 18+

Code: NCT04691817

Phase1, Phase2, Recruiting

A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis

for
Relapsed or Refractory Multiple Myeloma,
Location: Philadelphia PA, New York NY, Charlotte NC, Houston TX,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT05652335

Phase1, Recruiting

CAR-T Followed by Bispecific Antibodies

for
Large B-cell Lymphoma, DLBCL - Diffuse Large B Cell Lymphoma
Location: Philadelphia PA, Omaha NE
Sponsor: Abramson Cancer Center at Penn Medicine

Sex: All

Age: 18+

Code: NCT04889716

Phase2, Recruiting

A Randomized Phase 2 Trial of Nivolumab, Relatlimab Plus Ipilimumab vs. Nivolumab Plus Ipilimumab in First-line Advanced Renal Cell Carcinoma (RCC)

for
Renal Cell Carcinoma, Clear Cell
Location: Philadelphia PA, Boston MA, Durham NC, Nashville TN,
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06708949

Phase2, Recruiting

Autoimmunity After Checkpoint Blockade

for
Autoimmunity, Cancer, Immunotoxicity, Oncology
Location: Philadelphia PA
Sponsor: Abramson Cancer Center at Penn Medicine

Sex: All

Age: 18+

Code: NCT04119713

Recruiting